Trademark: 88744538
Status Date
Monday, August 2, 2021
Filing Date
Thursday, January 2, 2020
Published for Opposition
Tuesday, November 3, 2020
Abandoned Date
Monday, August 2, 2021
5 pharmaceutical preparations for the treatment of the treatment of acute respiratory diseases, central nervous system diseases, depression, including major depressive disorder (MDD), postpartum depression, and acute depression, anxiety, including Generalized Anxiety Disorder (GAD), insomnia, tremors, Huntington's disease, and Parkinson's disease
Aug 2, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 2, 2021
Abandonment - No Use Statement Filed
Dec 29, 2020
Noa E-Mailed - Sou Required From Applicant
Nov 3, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 3, 2020
Published For Opposition
Oct 14, 2020
Notification Of Notice Of Publication E-Mailed
Sep 25, 2020
Approved For Pub - Principal Register
Sep 24, 2020
Teas/Email Correspondence Entered
Sep 24, 2020
Correspondence Received In Law Office
Sep 24, 2020
Teas Response To Office Action Received
Mar 24, 2020
Notification Of Non-Final Action E-Mailed
Mar 24, 2020
Non-Final Action E-Mailed
Mar 24, 2020
Non-Final Action Written
Mar 24, 2020
Assigned To Examiner
Feb 10, 2020
Teas Change Of Correspondence Received
Jan 8, 2020
New Application Office Supplied Data Entered In Tram
Jan 6, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
